Results
1 -
10 of
24Brainstem Glioma: A Review, Current Neurology and Neuroscience Reports Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma, Current Treatment Options in Oncology Resistance to FLT3 Inhibitors, Resistance to Tyrosine Kinase Inhibitors FLT3 Inhibitors, Chemotherapy for Leukemia Leukemogenic potency of the novel FLT3-N676K mutant, Annals of Hematology A phase I trial of imatinib in combination with mFOLFOX6u2013bevacizumab in patients with advanced colorectal cancer, Cancer Chemotherapy and Pharmacology FLT3-Inhibitoren in der Therapie der akuten myeloischen Leuk??mie, best practice onkologie Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?, Targeted Oncology The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations, Investigational New Drugs CAR T-cells targeting FLT3 have potent activity against FLT3???ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib, Leukemia